Substance Use in the Performing Artist with Chronic Pain.
Substance Use in the Performing Artist with Chronic Pain.
复制标题
DOI：
10.21091/mppa.2022.1003
复制
发表时间：
2022-03
影响因子：
0.9
通讯作者：
中科院分区：
文献类型：
--
作者：
评估慢性疼痛的表演艺术家（PA）与非PA对照组相比，在物质使用测量方面可能存在差异。157名报告慢性疼痛的参与者（89名PA，68名非PA对照）完成了在线横断面调查。使用简明疼痛量表简表评估参与者自我报告的当前疼痛严重程度，使用疼痛患者筛选器和阿片类药物评估修订版评估阿片类药物滥用风险，使用主观阿片类药物戒断量表评估阿片类药物戒断，使用改良版DSM-V检查表评估阿片类药物使用障碍（OUD）症状。与非PA对照组相比，PA具有较低的疼痛严重度（p <0.05，t=2.196，df=155）和较低的疼痛干扰（p <0.05，t=2.194）。24%的PA和13%的对照组报告在过去一个月内使用阿片类药物。在PA中，过去一个月使用阿片类药物的天数与每周练习的时间呈正相关（r=0.508，p <0.05）。PA（66%）比对照组（44.1%，t=-2.136，χ2=7.72，p <0.01）更可能支持当前饮酒。重要的是，PA（19%）比对照组（3%）更有可能支持至少轻度OUD的症状（χ2（3）=11.3，p <0.01）和更高的阿片类药物滥用风险评级（t=-2.166，p <0.05）。PA中过去一个月阿片类药物戒断率也高于对照组（t=-2.136，p <0.05），5.6%的PA和1.5%的对照组报告在其一生中至少发生过一次阿片类药物过量事件（χ2=1.80，NS）。在慢性疼痛患者中，PA可能具有较高的阿片类药物相关后果风险，包括OUD，应在医疗保健过程中进行筛查。
To evaluate how performing artists (PAs) with chronic pain may differ on measures of substance use compared to non-PA controls. 157 participants reporting chronic pain (89 PAs, 68 non-PA controls) completed an online cross-sectional survey. Participants were assessed for self-reported current pain severity using the Brief Pain Inventory Short-Form, opioid misuse risk using the Screener and Opioid Assessment for Patients with Pain–Revised, opioid withdrawal using the Subjective Opiate Withdrawal Scale, and symptoms of opioid use disorder (OUD) using a modified version of the DSM-V checklist. PAs had lower pain severity (p <0.05, t=2.196, df=155) and lower pain interference (p <0.05, t=2.194) than non-PA controls. 24% of PAs and 13% of controls reported using opioids within the past month. Among PAs, the number of days using opioids in the past month was positively associated with hours spent practicing per week (r=0.508, p <0.05). PAs (66%) were more likely to endorse current alcohol use than controls (44.1%, t=−2.136, χ2=7.72, p <0.01). Importantly, PAs (19%) were more likely than controls (3%) to endorse symptoms of at least mild OUD (χ2(3)=11.3, p <0.01) and higher ratings of opioid misuse risk (t=−2.166, p <0.05). Past month opioid withdrawal was also greater in PAs than controls (t=−2.136, p <0.05), and 5.6% of PAs and 1.5% of controls reported at least one prior incident of opioid overdose in their lifetime (χ2=1.80, NS). Among persons with chronic pain, PAs may have higher risk for opioid-related consequences, including OUD, and should be screened during health care encounters.